128
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Tracking of Serum Lipoprotein (a) Concentration and Its Contribution to Serum Cholesterol Values in Children from 7 to 36 Months of Age in the STRIP Baby Study

, , , , &
Pages 541-547 | Received 10 Dec 1996, Accepted 10 Jun 1997, Published online: 20 Nov 2010

References

  • Pedro-Botet J, Senti M, Auguet T, et al. Apolipoprotein(a) genetic polymorphism and serum lipoprotein(a) concentration in patients with peripheral vascular disease. Atherosclerosis 1993; 104: 87–94
  • Brown S A, Morrisett J D, Boerwinkle E, Hutchinson R, Patsch W. The relation of apolipoprotein(a) concentration and apolipoprotein (a) phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993; 13: 1558–66
  • Shintani S, Kikuchi S, Hamaguchi H, Shiigai T. High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction. Stroke 1993; 24: 965–9
  • Bostom A G, Gagnon O R, Cupples L A, et al. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. Circulation 1994; 90: 1688–95
  • Maher V MG, Brown B G. Lipoprotein (a) and coronary heart disease. Curr Opin Lipidol 1995; 6: 229–35
  • Ridker P M, Hennekens C H, Stampfer M J. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 1993; 270: 2195–9
  • Fless G M, Snyder M L, Furbee J W, Garcia-Hedo M-T, Mora R. Subunit composition of lipoprotein (a) protein. Biochemistry 1994; 33: 13492–501
  • Marcovina S M, Morrisett J D. Structure and metabolism of lipoprotein (a). Curr Opin Lipidol 1995; 6: 136–45
  • Boerwinkle E, Leffert C C, Lin J, Lackner C, Chiesa G, Hobbs H H. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein (a) concentration. J Clin Invest 1992; 90: 52–60
  • Carlson L A, Hamsten A, Asplund A. Pronounced lowering of serum levels of lipoprotein Lp(a) in hyper-lipidaemic subjects treated with nicotinic acid. J Intern Med 1989; 226: 271–6
  • Hegele R A, Freeman M R, Langer A, Connelly P W, Armstrong P W. Acute reduction of lipoprotein (a) by tissue-type plasminogen activator. Circulation 1992; 85: 2034–8
  • Nestel P, Noakes M, Belling B, et al. Plasma lipoprotein lipid and tp(a) changes with substitution of elaidic acid for oleic acid in the diet. J Lipid Res 1992; 33: 1029–36
  • Mensink R P, Zock P L, Katan M B, Hornstra G. Effect of dietary cis and trans fatty acids on serum lipoprotein (a) levels in humans. J Lipid Res 1992; 33: 1493–501
  • Nydahl M C, Gustafsson L-B, Vessby B. Lipid lowering diets enriched with monounsaturated or polyunsaturated fatty acids but low in saturated fats have similar effects on serum lipid concentrations in hyperlipidemic patients. Am J Clin Nutr 1994; 59: 115–22
  • Ronnemaa T, Routi T, Lapinleimu H, et al. Serum lipoprotein (a) concentration in breast-fed and formula-fed infants. Nutr Metab Cardiovasc Dis 1994; 4: 188–91
  • Tholstrup T, Marckmann P, Vessby B, Sandstrom B. Effect of fats high in individual saturated fatty acids on plasma lipoprotein (a) levels in young healthy men. J Lipid Res 1995; 36: 1447–52
  • Routi T, Rönnemaa T, Lapinleimu H, et al. Effect of weaning on serum lipoprotein (a) concentration: the STRIP baby study. Pediatr Res 1995; 38: 522–7
  • Gavish D, Breslow J L. Lipoprotein(a) reduction by N-acetylcysteine. Lancet 1991; 337: 203–4
  • Berg A-L, Nilsson-Ehle P. Direct effects of corticotropin on plasma lipoprotein metabolism in man: studies in vivo and in vitro. Metabolism 1994; 43: 90–7
  • de Bruin T WA, van Barlingen H, van Linde-Sibenius Trip M, van Vuurst de Vries A-R, Akveld M J, Erkelens D W. Lipoprotein (a) and apolipoprotein B plasma concentrations in hepothyroid, euthyroid, and hyperthyroid subjects. J Clin Endocrinol Metab 1993; 76: 121–6
  • Sporik R, Johnstone J H, Cogswell J J. Longitudinal study of cholesterol values in 68 children from birth to 11 years of age. Arch Dis Child 1991; 66: 134–7
  • Kallio M JT, Salmenpera L, Siimes M A, Perheentupa J, Miettinen T A. Exclusive breast-feeding and weaning: effect on serum cholesterol and lipoprotein concentrations in infants during the first year of life. Pediatrics 1992; 89: 663–6
  • Porkka K VK, Viikari J SA, Taimela S, Dahl M, Åkerblom H K. Tracking and predictiveness of serum lipid and lipoprotein measurements in childhood: a 12-year follow-up. The Cardiovascular Risk in Young Finns Study. Am J Epidemiol 1994; 140: 1096–110
  • Kallio M JT, Salmenperä L, Siimes M A, Perheentupa J, Miettinen T A. Tracking of serum cholesterol and lipoprotein levels from the first year of life. Pediatrics 1993; 91: 949–54
  • Li K M, Wilcken D EL, Dudman N PB. Effect of serum lipoprotein(a) on estimation of low-density lipoprotein cholesterol by the Friedewald formula. Clin Chem 1994; 40: 571–3
  • Van Biervliet J P, Labeur C, Michiels G, Usher D C, Rosseneu M. Lipoprotein (a) profiles and evolution in newborn. Atherosclerosis 1991; 86: 173–81
  • Wang X L, Wilcken D EL, Dudman N PB. Early expression of the apolipoprotein (a) gene: relationships between infants' and their parents' serum apolipoprotein (a) levels. Pediatrics 1992; 98: 401–6
  • Rifai N, Heiss G, Doetsch K. Lipoprotein(a) at birth, in blacks and whites. Atherosclerosis 1992; 92: 123–9
  • Lapinleimu H, Viikari J, Jokinen E, et al. Prospective randomised trial in 1062 infants of diet low in saturated fat and cholesterol. Lancet 1995; 345: 471–6
  • Räsänen L, Ylönen K. Food consumption and nutrient intake of one-to two-year-old Finnish children. Acta Paediatr 1992; 81: 7–11
  • Panteghini M, Pagani F. Pre-analytical, analytical, and biological sources of variation of lipoprotein (a). Eur J Clin Chem Clin Biochem 1993; 31: 23–8
  • Desmarais R L, Sarembock I J, Ayers C R, Vernon S M, Powers E R, Gimble L W. Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty. Circulation 1995; 91: 1403–9
  • Kronenberg F, Trenkwalder E, Dieplinger H, Utermann G. Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail. Arterioscler Thromb Vase Biol 1996; 16: 1568–72
  • März W, Siekmeier R, Gross E, Gross W. Determination of lipoprotein (a): enzyme immunoassay and immunoradio-metric assay compared. Clin Chim Acta 1993; 214: 153–63
  • Siedel J, Hägele E O, Ziegenhorn J, Wahlefeld A W. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983; 29: 1075–80
  • Dahlén G H. Potential significance of Lp(a) lipoprotein: clinical and methodological aspects. Genetics of Coronary Heart Disease, A G Beam. Jon. Nordahls Trykkeri, Oslo 1992; 75–88
  • Routi T, Rönnemaa T, Salo R, et al. Effects of prospective, randomized cholesterol-lowering dietary intervention and apolipoprotein E phenotype on serum lipoprotein(a) concentrations of infants aged 7–24 mo. Am J Clin Nutr 1996; 63: 386–91
  • Olivecrona H, Johansson A G, Lindh E, Ljunghall S, Berglund L, Angelin B. Hormonal regulation of serum lipoprotein (a) levels. Contrasting effects of growth hormone and insulin-like growth factor-l. Arterioscler Thromb Vase Biol 1995; 15: 847–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.